Effects of NAC on outcome variables in COPD patients

M. L. Decramer, M. Rutten-Von Mölken, R. P. N. Dekhuijzen, T. Troosters, I. Lankhorst, B. Investigators (Leuven, Belgium; Rotterdam, Nijmegen, The Netherlands; Bresson, Italy)

Source: Annual Congress 2004 - Clinical and behavioural consequences of COPD
Session: Clinical and behavioural consequences of COPD
Session type: Poster Discussion
Number: 213
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. L. Decramer, M. Rutten-Von Mölken, R. P. N. Dekhuijzen, T. Troosters, I. Lankhorst, B. Investigators (Leuven, Belgium; Rotterdam, Nijmegen, The Netherlands; Bresson, Italy). Effects of NAC on outcome variables in COPD patients. Eur Respir J 2004; 24: Suppl. 48, 213

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of comorbidities on severity and clinical parameters of COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

The main predictors and consequences of osteosarcopenia in COPD patients
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


Influence of gender on health status response to long-term oxygen therapy in very severe COPD patients
Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients
Year: 2009


Comparison of comorbidities between two different subgroups in combined assessment of COPD
Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease
Year: 2016

Effect of smoking on lung functions in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 157s
Year: 2005

Effect of erdosteine in moderately severe COPD patients
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


Comparison of prognostic significance of the quality of life questionnaires in patients with COPD combined with hypertension
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


Effect of treatment on conditioning function indices in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 296s
Year: 2005

Effects of roflumilast in highly symptomatic COPD patients
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012


Effect of oral N-acetylcysteine treatment on systemic inflammatory status in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 716s
Year: 2005

Effect of patients‘ characteristics and asthma management on control
Source: Eur Respir J 2005; 26: Suppl. 49, 381s
Year: 2005

Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Gender-dependent predictors for survival in patients with COPD
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019

Effects of nutritional status on dyspnea in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 253s
Year: 2002

Effects of Hochuekkito combined with pulmonary rehabilitation in patients with COPD
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017

Effects of heliox-therapy on saturation and of survival patients with execerbation of COPD
Source: Annual Congress 2007 - Exercise: measurements, techniques and paradigms
Year: 2007


Comparative assessment of hemodynamic parameters in patients with COPD and CHD treated with different groups of bronchodilators.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018

Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Effects of pulmonary rehabilitation treatment on cognitive performance in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 569s
Year: 2007

The impact of depression in recovery and outcome of patients hospitalized for COPD exacerbation
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011